Optimal Entry Zone
$90-$95: A strategic accumulation zone for long-term positions. Monitor for reversal patterns (double bottom, bullish engulfing candlesticks).
Targets
$110: First resistance zone (aligned with the 200-day SMA and Ichimoku Base Line).
$124.65: Analyst average price target and major resistance. Represents a potential 27% upside from the current price.
$140+: Long-term stretch target if bullish fundamentals align.
Stop Loss
Below $84, as a breakdown of this level could indicate extended bearish momentum.
Patience is critical for this setup. Allow the stock to establish a firm bottom around $90-$95 and wait for confirmation of reversal via technical indicators or bullish news catalysts. If the sector strengthens or macroeconomic conditions favor defensive stocks, Merck could provide a solid long-term opportunity in 2025.
$90-$95: A strategic accumulation zone for long-term positions. Monitor for reversal patterns (double bottom, bullish engulfing candlesticks).
Targets
$110: First resistance zone (aligned with the 200-day SMA and Ichimoku Base Line).
$124.65: Analyst average price target and major resistance. Represents a potential 27% upside from the current price.
$140+: Long-term stretch target if bullish fundamentals align.
Stop Loss
Below $84, as a breakdown of this level could indicate extended bearish momentum.
Patience is critical for this setup. Allow the stock to establish a firm bottom around $90-$95 and wait for confirmation of reversal via technical indicators or bullish news catalysts. If the sector strengthens or macroeconomic conditions favor defensive stocks, Merck could provide a solid long-term opportunity in 2025.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.